← Leaderboards
Rebecca Marie Lynch
George Washington University
$8,681,221
Attributed
$12,942,704
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,942,704 · 8
By mechanism
U01$6,685,272 · 1
R01$3,605,634 · 1
R61$1,393,570 · 1
R21$895,713 · 2
K22$264,701 · 1
P30$97,814 · 2
Top collaborators
- Alberto Bosque5 shared
- Katharine June Bar4 shared
Most similar at George Washington University
Same institution · by research overlap
- David I Watkins$75,196,434
- Sherry Davis Molock$726,055
- Mudit Tyagi$3,464,695
- David Joseph Diemert$4,367,462
- Joel C Kuipers$561,605
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1AntibodiesClinical TrialsIn VitroVirus ReplicationVirusEpitopesNeutralizing AntibodyPublishingSamplingResistanceMutationPathway InteractionsImmunotherapyPreventionResponsePressureViralPlasmaMolecular VirologyIn VivoInfectionBindingDesign
Grant awards (24)
Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1$1,849,302
U01 · FY2025 · AI
Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening$493,865
R61 · FY2025 · AI · contact PI
HIV Persistence and Cure SWG$21,891
P30 · FY2025 · AI · contact PI
Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1$1,927,304
U01 · FY2024 · AI
Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies$721,590
R01 · FY2024 · AI · contact PI
Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening$449,464
R61 · FY2024 · AI · contact PI
Defining HIV Env protein expression in latently infected cells$201,875
R21 · FY2024 · AI · contact PI
HIV Cure Scientific Working Group$19,365
P30 · FY2024 · AI · contact PI
Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1$1,427,237
U01 · FY2023 · AI
Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies$694,664
R01 · FY2023 · AI · contact PI
Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening$450,241
R61 · FY2023 · AI · contact PI
Defining HIV Env protein expression in latently infected cells$242,250
R21 · FY2023 · AI · contact PI
HIV Cure Scientific Working Group$14,832
P30 · FY2023 · AI · contact PI
Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1$1,481,429
U01 · FY2022 · AI
Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies$742,884
R01 · FY2022 · AI · contact PI
HIV Cure Scientific Working Group$14,060
P30 · FY2022 · AI · contact PI
Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies$712,648
R01 · FY2021 · AI · contact PI
HIV Cure Scientific Working Group$11,684
P30 · FY2021 · AI · contact PI
Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies$733,848
R01 · FY2020 · AI · contact PI
Effects of boosting mucosal immunity by microbiota manipulation on B cell responses to HIV-1 vaccine$198,800
R21 · FY2020 · AI · contact PI
HIV Cure Scientific Working Group$15,982
P30 · FY2020 · AI · contact PI
Effects of boosting mucosal immunity by microbiota manipulation on B cell responses to HIV-1 vaccine$252,788
R21 · FY2019 · AI · contact PI
Replication cost to HIV-1 after escape from broadly neutralizing antibodies$106,701
K22 · FY2017 · AI · contact PI
Replication cost to HIV-1 after escape from broadly neutralizing antibodies$158,000
K22 · FY2016 · AI · contact PI